Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: Adults with type 2 diabetes and established CVD (but no CKD)

Generated Narrative: Group 236533

version: 65; Last updated: 2025-03-20 18:40:09+0000

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

RelatesTo

  • type: part-of
  • targetReference: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

url: https://fevir.net/resources/Group/236533

identifier: FEvIR Object Identifier/https://fevir.net/FOI/236533, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-population-group-85390-85789

name: Adults_with_type_2_diabetes_with_moderate_CV_risk

title: Adults with type 2 diabetes and established CVD (but no CKD)

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

membership: Conceptual